Live Journal Club
On December 18, 2023, the TER coordinators Allison Mo, Susan Brunskill and Catherine Kimber held a Live Journal Club where they invited the reviewers to discuss selected papers from the Round-Up.
Introduction
Welcome to the quarterly Transfusion Evidence Round-Up.
This is a collaboration between the International Society of Blood Transfusion (ISBT) and the Transfusion Evidence Library (TEL). We aim to highlight high quality evidence randomised controlled trials and systematic reviews about an internationally relevant subject in the field of Transfusion Medicine. All references are drawn from the Transfusion Evidence Library and, where relevant, Stem Cell Evidence.
This Transfusion Evidence Round-Up is sent to ISBT members and TEL subscribers, so if you are a subscriber to both mailing lists and receive it twice please bear with us until we can resolve this.
The Transfusion Evidence Library is produced by the Systematic Review Initiative (SRI) and funded by the four UK blood services. It is available free at the point of access providing a comprehensive and up-to-date database of high quality evidence in Transfusion Medicine.
Top 10 articles
Like always in the Round-Ups, 10 articles were selected from the Transfusion Evidence Library by 4 reviewers: Zoe Loh, Jules Zinni, Juan Manuel Cisneros Carrasco, Claire Iannizzi
Top article
Efficacy and safety of early administration of 4-factor prothrombin complex concentrate in patients with trauma at risk of massive transfusion: the PROCOAG randomized clinical trial. Bouzat, P., et al (2023). JAMA.
Selected articles
These articles were discussed during the Live Journal Club.
Efficacy and safety of early administration of 4-factor prothrombin complex concentrate in patients with trauma at risk of massive transfusion: the PROCOAG randomized clinical trial.
Bouzat, P., et al (2023). JAMA.
Effect of donor sex on recipient mortality in transfusion.
Chasse, M., et al. (2023). The New England Journal of Medicine.
Effect of single-unit transfusion in patients treated for haematological disease including acute leukemia: a multicenter randomized controlled clinical trial.
Chantepie, S.P., et al. (2023). Leukemia Research.
Pathogen inactivation methods to prevent transfusion-transmissible arboviruses.
Giménez-Richarte, Á., et al. (2023). Tropical Medicine & International Health.
Prehospital tranexamic acid for severe trauma.
Gruen, R. L., et al. (2023). The New England Journal of Medicine.
Convalescent plasma for people with COVID-19: a living systematic review
Iannizzi, C., et al. (2023). The Cochrane Database of Systematic Reviews.
Comparison of quantitative and calculated postpartum blood loss after vaginal delivery.
Madar, H., et al. (2023). American Journal of Obstetrics & Gynecology.
Two-year outcomes following a randomised platelet transfusion trial in preterm infants.
Moore C.M., et al. (2023). Archives of Disease in Childhood. Fetal and Neonatal Edition.
Men who have sex with men and risk for transfusion-transmissible infections in blood donors in Western countries: a systematic review update.
Schroyens, N., et al. (2023). Vox Sanguinis.
Platelet transfusion before CVC placement in patients with thrombocytopenia.
Van Baarle, F.L.F., et al. (2023). The New England Journal of Medicine.
Editorial Board
Zoe Loh
Dr Zoe Loh is a clinical and laboratory haematology trainee in Melbourne, Australia, who is in her final year of specialist training. She is interested in both malignant and non-malignant haematology, but has a particular enthusiasm for transfusion medicine and immunohaematology. She also enjoys and is actively involved in clinical research, and has several published papers.
Jules Zinni
Jules Zinni is supervisor of Immunology, Molecular Biology and Flow Cytometry at Elmhurst Memorial Hospital in Elmhurst, Illinois, United States. He began his career in transfusion medicine at tertiary and quaternary care facilities in Chicago and the Chicagoland area before moving to the immunohematology reference laboratory. He has experience in blood banking, transfusion services, cellular therapy, molecular testing, level I trauma centers and teaching. He contributes to abstract publications with Top Poster designations at AABB and ASCP annual meetings. He greatly appreciates the opportunity to serve as a guest member of the ISBT Transfusion Red Cell Immunogenetics and Blood Group Terminology Working Party and a former member-at-large for the Illinois Association of Blood Banks. He is an advocate for transfusion education for people within and ancillary to the field.
Juan Manuel Cisneros Carrasco
Dr Juan Manuel Cisneros Carrasco is a medical specialist in Clinical Pathology. He is Head of the Blood Bank at the Aranda de la Parra Hospital, in Leon, Guanajuato, Mexico. He is also an educator and trainer on transfusion medicine issues and promoter of voluntary blood donation. Dr Carrasco is University professor at La Salle University in the disciplines of microbiology and health sociology, and also an opinion columnist writer at Periódico AM.
Systematic Research Initiative
The Systematic Review Initiative (SRI) is a clinical research group established in 2001 by NHS Blood and Transplant (NHSBT) and funded by the UK Blood Services. The primary objective of the SRI is to “develop the evidence base for the practice of transfusion medicine”, by undertaking systematic reviews and other evidence-based medicine research projects in the transfusion field. @sritransfusion
- Twitter:
- @sritransfusion
Transfusion Evidence Library
The Transfusion Evidence Library is a database of systematic reviews and randomised controlled trials relevant to transfusion medicine. It is fully searchable, updated monthly and aims to be a key resource for medical practitioners, policy makers and researchers both in the UK and around the world. A monthly email: The Transfusion Evidence Alert with the latest top 10 records is sent to subscribers. The library is produced by the Systematic Review Initiative and funded by the UK Blood Services.
- Twitter:
- @transfusionlib
Stem Cell Evidence
Stem Cell Evidence is a comprehensive collection of high quality research relevant to haematopoietic stem cell transplantation, updated monthly. The most important articles in the field are highlighted in the Stem Cell Evidence Alert which is a newsletter emailed to subscribers. Stem Cell Evidence aims to be a key resource worldwide for medical practitioners, clinical researchers and policy makers. It is also intended to be of value to those planning new clinical trials in the field. It is produced by the Systematic Review Initiative and funded by the UK Blood Services and Oxford Biomedical Research Centre.
- Twitter:
- @evidencestemc
